awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q22252863-9CEE8E33-DC1F-4ED8-81A3-95C649A132F0
Q22252863-9CEE8E33-DC1F-4ED8-81A3-95C649A132F0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q22252863-9CEE8E33-DC1F-4ED8-81A3-95C649A132F0
Multiple Sclerosis: Where Will We Be in 2020?
P2860
Q22252863-9CEE8E33-DC1F-4ED8-81A3-95C649A132F0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q22252863-9CEE8E33-DC1F-4ED8-81A3-95C649A132F0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
553fa9f902b4793d5c49a16abf5b3546b56a2300
P2860
Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial.